A Two-Part Study to Determine Bioequivalence Between the MK-1084 Film-Coated Tablet and Oral-Compressed Tablet and the Effect of Food on the Single-Dose Pharmacokinetics of the MK-1084 Film-Coated Tablet in Healthy Adult Participants
Latest Information Update: 28 May 2025
At a glance
- Drugs MK-1084 (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacokinetics
- Sponsors Merck Sharp & Dohme
Most Recent Events
- 20 May 2025 Status changed from not yet recruiting to recruiting.
- 12 May 2025 New trial record